Webinars
Available On Demand
Secure success in bringing your novel therapies to market with Trinity’s innovative, holistic approach to valuing early-stage assets.
Biopharma companies have been experiencing record levels of growth in recent years through M&A, co-developments, joint ventures, licensing agreements and other partnership deals. It is unlikely that this accelerated growth would have been sustained using traditional methodologies that are less able to generate realistic valuations for complex innovative therapies. Using traditional valuation methods, we likely would not have seen the commercialization of…
Watch Now
Webinars
Available On Demand
Whether you are an emerging, mid-tier or large-tier company preparing for launch, now is the time to challenge conventional thinking.
We have all seen the dramatic shifts in scientific innovation in the life sciences industry that have been further accelerated by the COVID-19 pandemic. Despite these shifts, Trinity Life Sciences found that the commercial models employed by companies that launched new products recently were still largely based on traditional sales and marketing approaches.
In reaction to these findings, our experts…
Watch Now
Webinars
Available On Demand
What do ‘pricing inflation penalties’ actually mean for manufacturers of biopharma products?
Explore the impact of the Inflation Reduction Act (IRA) on biopharmaceutical product net prices and contract strategies as manufacturers adapt to new U.S. market conditions.
In this webinar, Trinity Life Sciences’ Evidence, Value, Access & Pricing practice experts will provide a high-level review of IRA policy updates before exploring the implications for currently marketed Medicare Part B and Part D therapies, as well as for future product launches.…
Watch Now
Webinars
Available On Demand
Demonstrating and communicating the value story to clinicians and payers is critical for successful commercialization, but there are many scenarios where new products may struggle to differentiate themselves. If you have a better mousetrap, how do you demonstrate value to support pricing, access, adoption and reimbursement?
The HEOR Evidence Strategy team at Trinity Life Sciences will conduct a webinar to explore this important question and share several case studies where we worked with companies facing this challenge. We will also…
Watch Now
Webinars
Available On Demand
What do pharmaceutical manufacturers need to know to successfully navigate the market access landscape in China through the latest NRDL update?
The access landscape in China is rapidly evolving with important implications for novel medicines. The most recent update of China’s National Reimbursement Drug List (NRDL) in 2021 focused on the expansion of new and high-cost innovative therapies and highlighted the improving access environment for these drugs.
In this webinar, Trinity Life Sciences’ Value, Access and Pricing experts will provide…
Watch Now
Webinars
Available On Demand
The U.S. market access landscape is becoming increasingly competitive and complex. It is now more important than ever for drug manufacturers to keep abreast of what payers are thinking to maximize the likelihood of receiving favorable reimbursement outcomes.
Through in-depth and ongoing conversations with Pharmacy Benefit Managers (PBMs) and Managed Care Organizations (MCOs), Trinity’s Value, Access and Pricing experts uncover what payers believe to be the most critical factors shaping pricing and market access decision-making for manufacturers over the next…
Watch Now
Webinars
Available On Demand
Trinity invites forecasting executives in the life sciences industry to join us for a lively discussion on establishing a forecasting ecosystem:
How do you set up an ecosystem that houses market/competitor dynamics, product demand, market access, promotional efforts, contracting, returns/stocking/inventory information, etc…?
Once you have this ecosystem, what are some best practice approaches to having key stakeholders easily access and update?
Susheel Sukhtankar, Partner & Head of Commercial Analytics at Trinity, will host this session and moderate a panel with…
Watch Now
Webinars
Available On Demand
The demand for experienced talent coupled with changing work models during the pandemic has created a very competitive job market. Biopharma companies are challenged more than ever with how to recruit, retain and motivate talent.
Join Trinity Life Sciences for a webinar that explores the findings from our recent TGaS study entitled, ‘Recruiting, Retaining and Motivating Talent’. Interviews were conducted with 27 Chief Commercial Officers at pre-commercial and emerging companies to understand how the biopharma industry is addressing this significant…
Watch Now
Webinars
Available On Demand
Join Trinity Life Sciences for a webinar that explores the findings from our TGaS report entitled, ‘Reimagining Work Models in the Life Sciences: Implications for the Future of Work’. Life sciences companies have been examining policies and addressing how and where employees should work. Many lack objective sources of data to make informed decisions. TGaS led a study with a Commercial Operations department at a pharmaceutical company to help validate or debunk certain industry work-model assumptions.
Are you interested in…
Watch Now
Webinars
Available On Demand
Join Trinity Life Sciences for a webinar that explores the findings from our TGaS report entitled, ‘Commercial and Medical Affairs Leaders Landscape 2022’. The study is based on the responses of 35 Commercial leaders and 24 Medical Affairs leaders representing 56 separate biopharmaceutical companies.
Commercial and Medical Affairs teams continue to play an important role in healthcare innovation and the value of having cross-functional collaboration is more critical than ever.
Join us for a dynamic discussion as we cover the…
Watch Now
